Does Cigna cover Wegovy for weight loss?

Which Wegovy forms does Cigna list?

Coverage in 2026 often differs by form, so check yours before you fill a prescription.

• Wegovy pensVaries by plan

  Express Scripts names them among the preferred weight-loss options on its National Preferred Formulary.

  Source: Express Scripts, 2026 National Preferred Formulary Exclusions (dated October 1, 2026)

• Wegovy HDVaries by plan

  Express Scripts names it among the preferred weight-loss options on its National Preferred Formulary.

  Source: Express Scripts, 2026 National Preferred Formulary Exclusions (dated October 1, 2026)

• Wegovy tabletsVaries by plan

  Express Scripts names them among the preferred options, and Cigna publishes a separate prior authorization policy for them.

  Source: Cigna, Weight Loss: GLP-1 Agonists, Wegovy Tablet Prior Authorization Policy (CNF1009) (review date June 17, 2026)

What does Cigna publish about Wegovy?

Here is each rule in the document's own words. A gap means the document did not say, and it is not a no.

We read these documents on October 15, 2026. Each one carries its own date in the source column.

Who decides whether your Cigna plan covers Wegovy?

Three parties shape the answer, and if you have coverage through work, your employer makes the final call.

1. 1. Your pharmacy benefit manager

   Express Scripts belongs to Evernorth, the Cigna Group's health services arm, and runs prescription plans for employers and health plans.

   Evernorth, the health services division of The Cigna Group Evernorth (The Cigna Group), Evernorth launches new benefit option that drives lower net cost for weight loss medicines (May 21, 2025)

2. 2. Your employer

   Express Scripts says a drug on its list can still be missing from your plan, because your employer or plan sponsor picks the benefit.

   Not all the medications listed are covered by all prescription plans Express Scripts, 2026 National Preferred Formulary Exclusions (dated October 1, 2026)

3. 3. Cigna's own policy

   Cigna writes that your plan document wins whenever it conflicts with a published coverage policy.

   A CUSTOMER'S BENEFIT PLAN DOCUMENT ALWAYS SUPERSEDES THE INFORMATION IN THE COVERAGE POLICIES Cigna, Weight Loss: GLP-1 Agonists, Zepbound Prior Authorization Policy (CNF1006) (review date June 17, 2026)

That is why two people with the same insurance card can get opposite answers: one employer bought weight-loss coverage and the other did not.

How does prior authorization for Wegovy work at Cigna?

Your prescriber asks Cigna to approve Wegovy before your pharmacy fills it, and the first approval lasts 8 months.

• First approval8 monthsfor weight loss in adults
• Each renewal1 yearonce you have finished the first 8 months
• Renewal weight test5% lostfrom your weight before any GLP-1

Terms from Cigna, Weight Loss: GLP-1 Agonists, Wegovy Injection Prior Authorization Policy (CNF1010) (review date June 17, 2026), read October 15, 2026.

Cigna's Wegovy injection policy also has routes for cutting heart risk in people with established heart disease, and for a liver condition called MASH, prescribed by or with a specialist. The document says: Major Adverse Cardiovascular Event(s) Risk Reduction.

Source: Cigna, Weight Loss: GLP-1 Agonists, Wegovy Injection Prior Authorization Policy (CNF1010) (review date June 17, 2026).

How do you find out if your Cigna plan covers Wegovy?

Check the drug list, then call. It takes about four steps.

1. Log in at express-scripts.com/covered to see whether your plan covers the drug and to compare prices. Express Scripts names that page on its formulary documents. (Express Scripts, 2026 National Preferred Formulary Exclusions (dated October 1, 2026))
2. Call the number on your prescription ID card and ask the questions below. (Express Scripts, 2026 National Preferred Formulary Exclusions (dated October 1, 2026))
3. If your prescriber needs to ask for an exception, the request goes through the Express Scripts portal at esrx.com/PA. (Express Scripts, 2026 National Preferred Formulary Exclusions (dated October 1, 2026))
4. Ask your HR or benefits team whether your plan covers weight-loss drugs, and whether it uses Cigna's standard policy or an EncircleRx version.

Write down the name of the person you spoke with, the date and any reference number. You need them if you appeal.

Want a printable version? Our insurance lookup tool builds the same questions for any plan type, including Medicaid and the Marketplace.

What are your three ways to pay for Wegovy?

Your route depends on whether your plan covers it, whether you have Medicare, or whether you pay cash.

1. Your plan covers it

If your plan approves Wegovy, Novo Nordisk's savings card can lower what you pay at the pharmacy, by at most $100 per month off. You cannot use it with government insurance: the copay offer is for commercial insurance; people on government insurance can use the self-pay prices only by paying outside their plan.

We read the Novo Nordisk savings terms on September 4, 2026. Your copay itself depends on your plan.

2. You have Medicare

If you have Medicare Part D, the Medicare GLP-1 Bridge charges $50 per monthly supply if you qualify. It covers the Wegovy injection and the Wegovy pill. See how the Bridge works or check your eligibility.

We checked CMS's Bridge guidance on September 26, 2026. Medicare's own checker is at medicare.gov.

3. Your plan says no, so you pay cash

• Novo Nordisk self-payfrom $199/moNovoCare self-pay: pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent

We checked the Novo Nordisk self-pay page on September 20, 2026. You still need a prescription.

Compounded semaglutide costs less, and it is not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or quality before they are sold, so talk it through with a licensed clinician. Read the FDA's explanation, then compare compounded semaglutide prices.

If Cigna says no, which denials can you appeal?

Three kinds of no reach you, and only some of them are worth an appeal.

1. 1. Your plan excludes weight-loss drugs

   Usually not appealable on medical grounds

   Your employer or plan left weight-loss drugs out, so meeting the medical criteria does not change the answer. Ask HR whether coverage changes at your next renewal, and ask your prescriber whether another approved use for Wegovy applies to you.

   Cigna publishes EncircleRx policies that override a plan's weight-loss exclusion only above stricter BMI lines, and Cigna writes that those lines are not clinical. The BMI thresholds for the weight loss indications in adults are not based on clinical data Cigna, Zepbound Benefit Exclusion Overrides Policy for EncircleRx BMI 35 (CNF1012) (review date June 17, 2026)

2. 2. You do not meet the criteria yet, or paperwork is missing

   Appealable

   Your plan covers the drug but the request did not show the BMI, program history or other criteria. Ask for the written reason, then have your prescriber resubmit or appeal with chart notes. A denial that rests on medical judgment can go to an independent external review.

   HealthCare.gov lists denials that involve medical judgment among those you can take to external review. Any denial that involves medical judgment HealthCare.gov, External review (undated web page)

3. 3. Your plan prefers a different drug or form

   Ask for an exception, or switch

   Your plan covers weight-loss drugs but not this version of Wegovy, or wants you to try something else first. Your prescriber can switch you to the listed form or ask for a formulary exception with a medical reason.

   Express Scripts' 2026 National Preferred Formulary excludes the Zepbound KwikPen and vials and names the single-dose Zepbound pens among the preferred alternatives. ZEPBOUND KWIKPENS, ZEPBOUND VIALS Express Scripts, 2026 National Preferred Formulary Exclusions (dated October 1, 2026)

For a health plan sold under federal rules, you file an internal appeal within 180 days of the denial notice. Your denial letter states the deadline that applies to your own plan.

Source: HealthCare.gov, Internal appeals (undated web page), read October 15, 2026.

Questions people ask about Cigna and Wegovy

Sources we read

1. Cigna, Weight Loss: GLP-1 Agonists, Wegovy Injection Prior Authorization Policy (CNF1010) (review date June 17, 2026)
2. Cigna, Weight Loss: GLP-1 Agonists, Wegovy Tablet Prior Authorization Policy (CNF1009) (review date June 17, 2026)
3. Cigna, Wegovy Injection Benefit Exclusion Overrides Policy for EncircleRx BMI 35 (CNF1020) (review date June 17, 2026)
4. Cigna, Cigna National Formulary coverage policies, A to Z (undated index)
5. Express Scripts, 2026 National Preferred Formulary Exclusions (dated October 1, 2026)
6. Express Scripts, 2027 National Preferred Formulary Exclusions (dated August 1, 2026)
7. Evernorth (The Cigna Group), Evernorth launches new benefit option that drives lower net cost for weight loss medicines (May 21, 2025)
8. HealthCare.gov, Internal appeals (undated web page)
9. HealthCare.gov, External review (undated web page)
10. Novo Nordisk, Wegovy savings terms (read September 4, 2026)
11. Novo Nordisk, Wegovy self-pay prices (read September 20, 2026)
12. CMS, Medicare GLP-1 Bridge information for Part D plans (read September 26, 2026)

We read the insurer and pharmacy benefit documents on October 15, 2026 and re-read them each January 1 and July 1, and when an insurer announces a mid-year change.